Related Experiment Video
Updated: Jun 20, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Locally recurrent rectal cancer in Norway
M H Hansen1, L Balteskard, L M Dørum
1Department of Digestive Surgery, University Hospital of North Norway, Tromsø, Norway. marit.helene.hansen@unn.no
The British Journal of Surgery
|September 30, 2009
Summary
Achieving a complete tumor removal (R0 resection) is crucial for improving survival in patients with recurrent rectal cancer. This factor significantly impacts long-term outcomes and treatment success.
Area of Science:
- Oncology
- Surgical Oncology
- Gastrointestinal Cancer Research
Background:
- Locally recurrent rectal cancer presents complex management challenges.
- Understanding treatment outcomes is vital for improving patient care.
Purpose of the Study:
- To analyze the management strategies and outcomes for patients diagnosed with locally recurrent rectal cancer.
- To provide insights based on data from the Norwegian Colorectal Cancer Registry.
Main Methods:
- Prospective national cohort study involving 577 patients with local recurrence after rectal cancer resection (R0/R1).
- Data collected from an initial cohort of 4504 patients between November 1993 and December 2001.
Main Results:
- 32.1% of patients underwent curative resections (R0/R1).
- 5-year overall survival was 14.9%. R0 resection yielded 55% 5-year survival, while R1 resection had 20%.
- Patients without metastases undergoing R0 resection showed a 62% 5-year survival rate.
Conclusions:
- Complete tumor resection (R0) is the most significant prognostic factor for recurrent rectal cancer.
- Effective management hinges on achieving clear surgical margins.
